Zeria Pharmaceutical Co., Ltd. (TYO:4559)
2,038.00
-30.00 (-1.45%)
Jun 13, 2025, 3:30 PM JST
Revenue by Product
Fiscal year is April - March.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | 2016 - 2018 |
Ethical Pharmaceutical | 49.57B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Ethical Pharmaceutical Growth | 14.89% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Consumer Healthcare | 26.00B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Consumer Healthcare Growth | 3.64% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 154.74M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 1.63% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 154.74M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 1.63% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is April - March.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | 2016 - 2018 |
Other | 5.03B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 2.53% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Japan | 36.75B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Japan Growth | 2.09% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe | 24.41B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe Growth | 21.11% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United Kingdom | 9.54B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United Kingdom Growth | 30.19% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 5.03B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 2.53% |
Log In |
Log In |
Log In |
Log In | Upgrade
|